Aptevo Therapeutics Inc (APVO)
0.7107
-0.04
(-5.23%)
USD |
NASDAQ |
Apr 30, 16:00
0.7107
0.00 (0.00%)
After-Hours: 18:30
Aptevo Therapeutics Net Income (Quarterly): -5.903M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -5.903M |
September 30, 2023 | -6.334M |
June 30, 2023 | -7.948M |
March 31, 2023 | 2.773M |
December 31, 2022 | -4.642M |
September 30, 2022 | -7.644M |
June 30, 2022 | 28.01M |
March 31, 2022 | -7.697M |
December 31, 2021 | -6.272M |
September 30, 2021 | -6.997M |
June 30, 2021 | -7.932M |
March 31, 2021 | -7.256M |
December 31, 2020 | -7.053M |
September 30, 2020 | -6.791M |
June 30, 2020 | -6.803M |
March 31, 2020 | 2.897M |
December 31, 2019 | -8.174M |
September 30, 2019 | -6.924M |
Date | Value |
---|---|
June 30, 2019 | -13.33M |
March 31, 2019 | -12.02M |
December 31, 2018 | -14.13M |
September 30, 2018 | -12.56M |
June 30, 2018 | -13.14M |
March 31, 2018 | -13.85M |
December 31, 2017 | -9.76M |
September 30, 2017 | 37.87M |
June 30, 2017 | -11.19M |
March 31, 2017 | -9.945M |
December 31, 2016 | -14.95M |
September 30, 2016 | -71.74M |
June 30, 2016 | -12.84M |
March 31, 2016 | -12.89M |
December 31, 2015 | -17.90M |
September 30, 2015 | -12.68M |
June 30, 2015 | -17.72M |
March 31, 2015 | -11.02M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-13.33M
Minimum
Jun 2019
28.01M
Maximum
Jun 2022
-4.422M
Average
-6.924M
Median
Sep 2019
Net Income (Quarterly) Benchmarks
Heron Therapeutics Inc | -10.72M |
Creative Medical Technology Holdings Inc | -1.679M |
BioSig Technologies Inc | -6.049M |
Adial Pharmaceuticals Inc | -1.920M |
IN8bio Inc | -7.598M |
Net Income (Quarterly) Related Metrics
Total Expenses (Quarterly) | 6.384M |
EPS Diluted (Quarterly) | -13.34 |
Enterprise Value | -16.50M |
Earnings Yield | -10.17K% |
Normalized Earnings Yield | -38094.47 |